Fate Therapeutics, Inc. (FATE) - Latest Market Data

Price & Market Data

Price: $2.24

Daily Change: +$0.141 / 6.29%

Daily Range: $2.06 - $2.31

Market Cap: $262,258,160

Daily Volume: 5,904,957

Performance Metrics

1 Week: 12.63%

1 Month: 50.72%

3 Months: 51.81%

6 Months: 109.5%

1 Year: 82.17%

YTD: 111.1%

About Fate Therapeutics, Inc. (FATE)

Stay informed with Fate Therapeutics, Inc. (FATE) market data. Current price: 2.24, daily change: +$0.141 / 6.29%. Market cap: 262,258,160. Performance over 1-month, 3-month, and 1-year.

Company Details

Employees: 161

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.

Selected stocks

Zhihu Inc. (ZH)

enGene Therapeutics Inc. (ENGN)

BeLive Holdings (BLIV)

Clear Channel Outdoor Holdings, Inc. (CCO)

OneMedNet Corp (ONMD)